Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$171.37 - $283.23 $514 - $849
-3 Reduced 0.54%
549 $146,000
Q4 2023

Jan 26, 2024

BUY
$120.4 - $237.13 $4,093 - $8,062
34 Added 6.56%
552 $127,000
Q3 2023

Nov 03, 2023

SELL
$146.04 - $225.78 $19,131 - $29,577
-131 Reduced 20.18%
518 $75,000
Q2 2023

Aug 04, 2023

SELL
$203.88 - $312.0 $199,802 - $305,760
-980 Reduced 60.16%
649 $149,000
Q1 2023

May 15, 2023

SELL
$231.06 - $307.08 $69,318 - $92,124
-300 Reduced 15.55%
1,629 $394,000
Q3 2022

Nov 16, 2022

BUY
$60.57 - $79.51 $11,084 - $14,550
183 Added 10.48%
1,929 $125,000
Q2 2022

Aug 01, 2022

SELL
$58.04 - $100.2 $9,924 - $17,134
-171 Reduced 8.92%
1,746 $170,000
Q1 2022

May 03, 2022

SELL
$55.89 - $101.89 $24,647 - $44,933
-441 Reduced 18.7%
1,917 $188,000
Q4 2021

Jan 21, 2022

BUY
$72.34 - $95.09 $46,225 - $60,762
639 Added 37.17%
2,358 $200,000
Q3 2021

Oct 20, 2021

SELL
$78.35 - $105.02 $2,115 - $2,835
-27 Reduced 1.55%
1,719 $137,000
Q2 2021

Jul 20, 2021

BUY
$97.2 - $137.59 $38,296 - $54,210
394 Added 29.14%
1,746 $170,000
Q1 2021

Apr 06, 2021

BUY
$108.54 - $125.2 $74,349 - $85,762
685 Added 102.7%
1,352 $158,000
Q4 2020

Jan 20, 2021

BUY
$110.06 - $133.7 $25,533 - $31,018
232 Added 53.33%
667 $74,000
Q3 2020

Nov 03, 2020

BUY
$99.78 - $124.21 $20,554 - $25,587
206 Added 89.96%
435 $52,000
Q2 2020

Jul 22, 2020

BUY
$60.13 - $125.71 $13,769 - $28,787
229 New
229 $26,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.94B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Liberty One Investment Management, LLC Portfolio

Follow Liberty One Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty One Investment Management, LLC with notifications on news.